Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2021-09-30 00:00:00 ET · period of report 2021-09-28 · accession 0001209191-21-058176 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-30 | 2021-09-28 | FATE | Dulac Edward J III | CFO | M - OptEx | $35.52 | +17.3K | 71.9K | +32% | +$615.4K |
| D | 2021-09-30 | 2021-09-28 | FATE | Dulac Edward J III | CFO | S - Sale+OE | $62.53 | -19.5K | 52.4K | -27% | -$1.22M |
| D | 2021-09-30 | 2021-09-28 | FATE | Dulac Edward J III | CFO | M - OptEx | $0.00 | -17.3K | 142.7K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-28 | M | A | 17,325 | $35.52 | 71,864 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-28 | S | D | 19,460 | $62.53 | 52,404 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-09-28 | M | D | 17,325 | $0.00 | 142,675 | D | $35.52 · — to 2030-08-17 | 17,325 Common Stock | (F2) The option shall vest as to 25% of the underlying shares on August 17, 2021 and thereafter on a monthly basis for 36 additional months, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date. |